Cargando…
Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives
Inflammatory bowel disease (IBD), which mainly consists of Crohn’s disease and ulcerative colitis, is a chronic and relapsing inflammatory condition of the gastrointestinal tract. The traditional treatment strategies relied on frequent administration of high dosages of medications, including antibio...
Autores principales: | Yang, Chunhua, Merlin, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859086/ https://www.ncbi.nlm.nih.gov/pubmed/32009785 http://dx.doi.org/10.2147/IJN.S210315 |
Ejemplares similares
-
Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy
por: Yang, Chunhua, et al.
Publicado: (2020) -
Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2019) -
Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems
por: Chandrakala, V., et al.
Publicado: (2022) -
Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis
por: Zhang, Mingzhen, et al.
Publicado: (2018) -
Novel Small Molecules in IBD: Current State and Future Perspectives
por: Jefremow, André, et al.
Publicado: (2023)